PERSPECTA

News from every angle

← Back to headlines

Akebia Plans Vafseo Price Reset and Reports VOICE Trial Results

Akebia Therapeutics intends to reset the price of Vafseo after December 31, 2026, following its TDAPA period, as the VOICE trial reported win odds of 1.16.

6 Aug, 02:41 — 6 Aug, 02:41
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed2h ago

Akebia plans Vafseo price reset after Dec. 31, 2026 TDAPA as VOICE trial posts win odds 1.16

Read full article →

Related Stories

Cyprus Tourism Featured in National Geographic's Reading List

12m ago

SmartStop Self Storage REIT Reports Q1 Earnings

14m ago

Hennessy Advisors Reports Q1 Financial Results

15m ago

SandRidge Energy Misses Q1 Earnings and Revenue Estimates

16m ago